fibrinogen has been researched along with Malignant Mesothelioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alimohammadi, A; Arns, M; Berger, W; Brcic, L; Dome, B; Filipits, M; Ghanim, B; Grusch, M; Hegedus, B; Hoda, MA; Jakopovic, M; Klepetko, W; Klikovits, T; Laszlo, V; Samarzija, M; Schenk, P; Winter, MP | 1 |
| Aigner, C; Bendek, M; Berger, W; Brcic, L; Dome, B; Dong, Y; Frauenfelder, T; Ghanim, B; Grusch, M; Hegedus, B; Hoda, MA; Jakopovic, M; Kao, SC; Kirschner, MB; Klepetko, W; Klikovits, T; Laszlo, V; Nguyen-Kim, TD; Opitz, I; Ozsvar, J; Reid, G; Rozsas, A; Samarzija, M; Stockhammer, P; Szirtes, I; van Zandwijk, N; Weder, W | 1 |
2 other study(ies) available for fibrinogen and Malignant Mesothelioma
| Article | Year |
|---|---|
Circulating fibrinogen is a prognostic and predictive biomarker in malignant pleural mesothelioma.
Topics: Biomarkers, Tumor; Combined Modality Therapy; Female; Fibrinogen; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Pleural Neoplasms; Prognosis; Retrospective Studies | 2014 |
Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional study.
Topics: Activins; Aged; Biomarkers, Tumor; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Pleural Neoplasms; Prognosis | 2016 |